Other technical consultancy
IMMUVERA THERAPEUTICS AS
Revenue 2024
NOK 220,000
Operating profit
NOK −5.9m
Equity
NOK 15.8m
Incorporated
2020
Share capital
NOK 69,000
Roles
Daglig lederJørund Sollid
Regnskapsfører
Styrets lederMarcus Sahlin Pettersen
StyremedlemKristin Malene Bjerke
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| ALV AS | 32.0% | 2088340.000000 | 2025 |
| ESTER 4.14 AS | 8.2% | 536200.000000 | 2025 |
| NISTADGRUPPEN AS | 4.7% | 310000.000000 | 2025 |
| AMBROSIA AS | 3.9% | 253300.000000 | 2025 |
| GANDALF AS | 2.7% | 177271.000000 | 2025 |
| POLAR PRODUCTION AS | 2.4% | 157000.000000 | 2025 |
| EDUARD EMILIAN GRIEG | 1.8% | 117396.000000 | 2025 |
| M3 HOLDING AS | 1.5% | 100000.000000 | 2025 |
| BRAK INVEST AS | 1.5% | 100000.000000 | 2025 |
| LARS BUER | 1.5% | 100000.000000 | 2025 |
| OSLO KAPITALFORVALTNING AS | 1.5% | 98000.000000 | 2025 |
| ECF HOLDING AS | 1.3% | 82200.000000 | 2025 |
| CHRISTIAN MJAASETH | 1.1% | 70000.000000 | 2025 |
| HM GRAM ENTERPRISES LTD (ΗΕ302283) | 1.0% | 66265.000000 | 2025 |
| GAZPACHO AS | 0.9% | 60000.000000 | 2025 |
| JJINVEST AS | 0.9% | 57786.000000 | 2025 |
| MOFA INVEST AS | 0.8% | 50450.000000 | 2025 |
| INGEBJØRG BRATLAND AS | 0.8% | 50000.000000 | 2025 |
| ASKAMA AS | 0.7% | 48720.000000 | 2025 |
| HANDSUP HOLDING AS | 0.6% | 40000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ALVIRAL AS | unknown | 99.0% | 297000.000000 |
| IMMUVERA THERAPEUTICS AS | Active | 0.2% | 11672.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.